Green Park and Golf Ventures’ New Fund Targets $30M Goal

The investment firm has closed on a third of the $30-million follow-on investment fund.


A Dallas investment firm that focuses on funding medical technology companies will be investing millions in companies that are showcasing beneficial products and technologies in the health-care industry, according to D CEO Healthcare’s Olivia Nguyen.

Green Park and Golf Ventures has closed on a third of it’s $30 million follow-on investment fund, D CEO Healthcare reported. From a portfolio of 40 seed and startup investments, the group will choose a select group of companies to receive extra funding.

The firm hopes to bring about 15 to 20 new investments over the next four to five years, D CEO reported. The full follow-on fund should close by December.


The bulk GPG investments have gone to medical technology devices, founding partner Carl Soderstrom told MedCity News. Soderstrom also serves as the co-founder of health-care accelerator, Health Wildcatters.

GPG told D CEO, they are seeking companies that are “currently raising money to complete pivotal studies of safety and effectiveness.”

The follow-on will continue GPG’s commitment to its portfolio. 70 percent of GPG’s investees have received follow-on funding, according to MedCity News.

Dr. Clay Heighten, founding partner of GPG, told D CEO, the company has seen “very strong successes within our existing portfolio, and [is] eager to continue to expand and invest in our best performing healthcare startups.”

Dallas Innovates, every day

One quick signup, and you’ll be on the list.   
View previous emails.


R E A D   N E X T